Pulling SEC filings + quote and writing the call…

HeartCore Enterprises, Inc.
Next earnings ≈ Aug 13, 2026 · est. from filing cadence
Last earnings -3.3% on 2026-05-15
HTCR's headline profit is a one-off divestiture gain — the core business shrank 60%, loses money at the operating line, and bleeds cash while paying dividends it can't fund.
Operating income -$3.12M · FY2025
It screens cheap (~173% below fair value), but the weak fundamentals are why — more potential value trap than bargain.
The optically cheap 13.9x P/E and 491% jump in net income are a mirage. HTCR sold its entire Japanese software business (HeartCore Japan) to Smith Japan on October 31, 2025, and the $5.79M of FY2025 net income is driven by that divestiture, not operations. The proof is in the split: operating income is -$3.12M (a -34.8% operating margin) and operating cash flow is also -$3.12M. A company that earns a 64.6% net margin while losing money on every operating dollar is not a profitable business — it is a business that sold assets. Revenue collapsed from $22.7M in FY2024 to $8.97M in FY2025 (-60.5%), and gross profit fell 78.6%, so the trailing P/S of 8.7x is being paid for a shrinking, unprofitable remnant.
What's left is an unproven pivot to the 'GO IPO' consulting business, which helps Japanese companies list in the US for per-deal fees of $380K–$900K plus 1%–4% warrants exercisable at $0.01. That model is inherently lumpy, tiny (16 agreements to date), and its warrant-based upside is non-cash and speculative — it depends entirely on client IPOs actually happening and holding value. Meanwhile the second remaining operating asset, the 51% stake in Sigmaways, is explicitly up for sale with 'no assurance that any transaction will be consummated,' so even the current revenue base is unstable. This is a company mid-teardown, and the forward economics of the surviving entity are effectively unknowable from the provided data.
Is HTCR a buy? The one-page verdict, explained →
AVOID means we wouldn't engage at all — if expressing the short side anyway, only with capped risk.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $10.8M | $8.82M | $21.8M | $22.7M | $8.97M |
| Gross profit | $5.19M | $3.35M | $8.07M | $14.7M | $3.15M |
| Operating income | $59.0K | -$6.70M | -$4.12M | -$162K | -$3.12M |
| Net income | -$338K | -$6.68M | -$4.19M | -$1.48M | $5.79M |
| Diluted EPS | -$0.02 | -$0.37 | -$0.21 | -$0.07 | $0.22 |
| Net margin | -3.1% | -75.7% | -19.2% | -6.5% | 64.6% |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
New agreement + closed asset sale (likely Sigmaways divestiture), completing GO IPO pivot
Q1 2026 10-Q: pared-down GO IPO-only company, small revenue base after Japan exit
Q1 2026 10-Q: pared-down GO IPO-only company, small revenue base after Japan exit
Reg FD/other-events business update, no financial impact disclosed
Charter/bylaw amendment (Item 5.03) — governance/share-structure change
Reg FD/other-events update, likely GO IPO consulting news; no numbers
FY2025 10-K: sold Japan software biz, revenue -60% to $8.97M, -$3.1M operating loss
FY2025 10-K: sold Japan software biz, revenue -60% to $8.97M, -$3.1M operating loss
Q3 2025 10-Q filed after NT delay; reflects HeartCore Japan sale transition
Sources: SEC EDGAR (CIK 0001892322, latest 10-Q filed 2026-05-15) · EODHD · Proprietary analysis · as of 7/4/2026, 10:11:09 AM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 4, 2026, 6:11 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
| 2025-05-30 | Yasui Daishin 10% owner | Sell | 60.0K @ $0.70 | $42.0K |
| 2025-05-29 | Yasui Daishin 10% owner | Sell | 50.0K @ $0.67 | $33.4K |
| 2025-05-21 | Yasui Daishin 10% owner | Sell | 869.00 @ $0.61 | $530.09 |
| 2025-05-20 | Yasui Daishin 10% owner | Sell | 10.0K @ $0.56 | $5.60K |
| 2025-03-21 | Yasui Daishin 10% owner | Sell | 2.50K @ $1.06 | $2.64K |
| 2025-03-19 | Yasui Daishin 10% owner | Sell | 300.00 @ $0.95 | $285.00 |
| 2024-11-19 | Kuno Keisuke CX Division Vice President | Sell | 10.0K @ $1.26 | $12.6K |
| 2024-11-19 | Kuno Keisuke CX Division Vice President | Sell | 10.0K @ $1.27 | $12.7K |
| 2024-11-19 | Kuno Keisuke CX Division Vice President | Sell | 6.00K @ $1.28 | $7.68K |
| 2024-10-01 | Yamamoto Sumitaka Chairman, CEO & President | Award | 45.9K | |
| 2024-10-01 | Kuno Keisuke CX Division Vice President | Award | 9.36K | |
| 2024-10-01 | Gao Qizhi Chief Financial Officer | Award | 6.05K |
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1195 tracked peers · median